Extra Super Levitra
Extra Super Levitra Price range: $ 99,00 through $ 530,00
Back to products
Extra Super Tadarise
Extra Super Tadarise Price range: $ 45,00 through $ 139,00

Extra Super P-Force

Price range: $ 72,00 through $ 199,00

Extra Super P-Force is a highly effective dual-action medication designed to address both erectile dysfunction and premature ejaculation simultaneously. Each tablet combines sildenafil citrate and dapoxetine to help men achieve a firm erection while providing significantly better control over the timing of climax. This advanced formula works by increasing blood flow to the pelvic area and regulating the body’s natural response to prolong the duration of intimacy. By targeting two common performance concerns at once, it offers a comprehensive solution for enhancing sexual stamina and overall confidence. Its reliable results make it a preferred choice for those seeking to improve their performance and enjoy a more satisfying personal life.

Active substance: Dapoxetine, Sildenafil Citrate
SKU: Extra Super P-Force Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Extra Super P-Force contains active components belonging to the classes of phosphodiesterase type 5 (PDE5) inhibitors and selective serotonin reuptake inhibitors (SSRIs). It is formulated to address complex male sexual dysfunction parameters by targeting distinct physiological mechanisms. Clinical management of this combined pharmacotherapy requires professional evaluation by a licensed healthcare practitioner.

The constituent active pharmaceutical ingredients–sildenafil citrate and dapoxetine hydrochloride–act simultaneously on vascular and central neurochemical pathways. Dispensing must strictly accord with applicable federal and state regulations, ensuring comprehensive screening for underlying cardiovascular, hepatic, renal, and psychiatric conditions prior to administration.

Parameter Specification
Active ingredients (INN) Sildenafil citrate, Dapoxetine hydrochloride
Therapeutic class PDE5 inhibitor / SSRI
Route of administration Oral
Primary purpose Co-management of erectile dysfunction and premature ejaculation
Prescription status Dispensed in accordance with applicable federal and state regulations
Storage conditions Controlled room temperature (20°C to 25°C / 68°F to 77°F)

Clinical Profile and Pharmacodynamics

How the drug works

The mechanism of action is mediated by two independent pharmacological pathways. Sildenafil acts as a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). By inhibiting PDE5, sildenafil prevents the enzymatic degradation of cGMP in the vascular smooth muscle cells of the corpus cavernosum, facilitating nitric oxide-driven vasodilation and increased penile blood inflow during sexual stimulation. Dapoxetine functions as a short-acting selective serotonin reuptake inhibitor (SSRI). It selectively inhibits presynaptic serotonin reuptake transporters, increasing 5-hydroxytryptamine (5-HT) activity within synaptic clefts of the central nervous system. This enhancement of serotonergic neurotransmission elevates the ejaculatory threshold and delays axonal transmission associated with the ejaculatory reflex.

Main uses

The primary clinical indication for this dual-active formulation is the concurrent treatment of erectile dysfunction (ED) and premature ejaculation (PE) in adult males aged 18 to 64 years. Erectile dysfunction involves the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. Premature ejaculation is characterized by persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration, causing marked distress or interpersonal difficulty. In the United States, while individual components such as sildenafil are FDA-approved under specific indications, fixed-dose combination formulations containing dapoxetine are not FDA-approved drug products and are subject to federal and state regulatory constraints.

What happens in the body

Pharmacokinetic parameters demonstrate distinct profiles for each active component. Sildenafil is rapidly absorbed following oral administration, achieving peak plasma concentration (Cmax) within 30 to 120 minutes (median 60 minutes) under fasted conditions. Absolute oral bioavailability is approximately 41%. Sildenafil and its primary circulating active metabolite (N-desmethylsildenafil) exhibit approximately 96% plasma protein binding. The terminal elimination half-life ranges from 3 to 5 hours. Dapoxetine is likewise absorbed rapidly, reaching Cmax within 1 to 2 hours post-dose. Absolute oral bioavailability for dapoxetine is approximately 42%. Dapoxetine binds extensively to plasma proteins (>99%). Both agents undergo prominent hepatic biotransformation: sildenafil is metabolized mainly by CYP3A4 (major pathway) and CYP2C9 (minor pathway), while dapoxetine is processed by CYP3A4 and CYP2D6. Elimination occurs via feces and urine.

Dosage, Safety, and Interactions

Dosing schedule

Administration guidelines necessitate taking one oral tablet with a full glass of water approximately 1 to 3 hours prior to anticipated sexual activity. The tablet must be swallowed whole without chewing, crushing, or splitting. The maximum recommended dosing frequency is once within a 24-hour period. Dose titration or adjustment must be conducted under direct medical supervision, taking into account individual physiological response, adverse effect profiles, and organ function. The preparation should not be ingested continuously on a daily regimen without explicit diagnostic rationale and medical monitoring.

Compatibility with other medicines

Co-administration with organic nitrates (e.g., nitroglycerin, isosorbide dinitrate, isosorbide mononitrate) or nitric oxide donors (such as amyl nitrate or nitrite) is strictly contraindicated due to the risk of severe, life-threatening hypotension. Concomitant use with monoamine oxidase inhibitors (MAOIs), other SSRIs, SNRIs, tricyclic antidepressants, or thioridazine is contraindicated; a minimum wash-out period of 14 days is required between discontinuation of MAOIs and initiation of dapoxetine-containing products. Potent CYP3A4 inhibitors (including ketoconazole, itraconazole, ritonavir, and clarithromycin) significantly elevate systemic concentrations of both sildenafil and dapoxetine, necessitating extreme caution or total avoidance. Co-administration with alpha-adrenergic blockers requires stabilization of antihypertensive therapy prior to initiation to reduce the risk of orthostatic hypotension.

Adverse reactions

Adverse events reported with PDE5 inhibitor and SSRI combinations reflect the individual side effect profiles of both active substances. Frequently reported PDE5-related adverse reactions include cephalalgia (headache), facial flushing, nasal congestion, dyspepsia, visual disturbances (cyanopsia, blurred vision), and dizziness. Commonly reported SSRI-related adverse effects include nausea, somnolence, fatigue, insomnia, diarrhea, dry mouth, and hyperhidrosis. Less common but severe adverse events encompass priapism (a painful erection persisting longer than 4 hours), sudden sensorineural hearing loss, non-arteritic anterior ischemic optic neuropathy (NAION), severe syncope, orthostatic hypotension, and serotonin syndrome.

Important precautions

Prior to initiating treatment, a thorough medical history and cardiovascular assessment are mandatory. Sexual activity entails inherent cardiac risk; therefore, treatment is unsuitable for individuals with unstable angina, severe heart failure (NYHA Class III or IV), recent myocardial infarction or stroke (within 6 months), severe hypotension (blood pressure < 90/50 mmHg), or uncontrolled hypertension. Patients with hepatic impairment (Child-Pugh Class B or C) or severe renal impairment (creatinine clearance < 30 mL/min) exhibit altered clearance and require careful clinical evaluation. The formulation is not indicated for use in female patients, pediatric populations, or males under 18 years of age. Patients with hereditary degenerative retinal disorders, such as retinitis pigmentosa, should avoid use.

What to avoid while taking it

Co-administration with high-fat meals delays the rate of gastrointestinal absorption of sildenafil, extending the time to reach peak concentration (Tmax) and potentially delaying the onset of clinical efficacy. Ingestion of grapefruit or grapefruit juice must be avoided, as grapefruit compounds inhibit intestinal CYP3A4 metabolism, resulting in elevated plasma concentrations of both active constituents. Concurrent ethanol (alcohol) consumption is strongly discouraged; alcohol exerts additive pharmacodynamic effects that increase the incidence and severity of central nervous system adverse events, including somnolence, dizziness, impaired motor coordination, syncope, and severe orthostatic hypotension.

Red flags

Immediate emergency medical intervention is required upon the manifestation of specific critical clinical events. Development of priapism–an erection lasting continuously for more than 4 hours–requires urgent urological intervention to prevent irreversible cavernous tissue necrosis and permanent erectile dysfunction. Emergent evaluation is required for sudden, painless decrease or loss of vision in one or both eyes, indicative of non-arteritic anterior ischemic optic neuropathy (NAION). Sudden decrease or total loss of hearing, accompanied by tinnitus or vertigo, demands prompt otolaryngological evaluation. Acute onset of chest pain, severe dyspnea, syncope, or manifestations of serotonin syndrome (e.g., hyperreflexia, tremor, rigidity, fever, and altered mental status) requires immediate emergency medical care.

Storage and expiration

The product must be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), with temporary excursions permitted between 15°C and 30°C (59°F to 86°F). Protect the medication from direct light and ambient moisture by maintaining tablets in their original blister packaging until immediate use. Keep all pharmaceuticals securely out of reach of children and domestic pets. Do not use the medication beyond the expiration date stamped on the outer packaging. Expired or unused medication should be disposed of via official community pharmaceutical take-back programs rather than household waste or wastewater systems.

What to ask your provider

Patients should review critical safety questions with their prescribing physician or pharmacist before initiating therapy:

  • Is my current cardiovascular condition stable enough to tolerate the physical strain of sexual activity?
  • How do my existing prescription medications, over-the-counter drugs, or dietary supplements interact with this combination?
  • What specific dosage adjustments are required based on my renal and hepatic blood laboratory parameters?
  • What emergency procedures should be initiated if I experience severe lightheadedness, syncope, or prolonged erections?

Common questions

What physiological consequences occur if alcohol is consumed concurrently with Extra Super P-Force?

Ethanol co-administration enhances the central nervous system depressive effects of dapoxetine and accentuates the vasodilatory action of sildenafil. This synergism significantly increases the incidence of orthostatic hypotension, syncope, dizziness, and impaired judgment. Clinical safety protocols advise total avoidance of alcohol during treatment.

Is it safe to divide or alter the physical tablet prior to ingestion?

The tablet is formulated to deliver a precise fixed combination of active substances. Splitting, crushing, or chewing the tablet alters the dissolution rate and bioavailability, potentially causing inconsistent plasma levels or severe local gastrointestinal irritation. Tablets must be swallowed whole with water.

How long after administration do the pharmacological effects typically persist?

The duration of action is governed by the elimination half-lives of both active ingredients. Sildenafil provides PDE5 inhibition typically lasting 4 to 6 hours post-dose. Dapoxetine undergoes rapid initial elimination, with its primary pharmacological window diminishing within several hours. Overall functional effects are maintained within a window of several hours following ingestion.

What steps should be taken if mild dizziness or lightheadedness develops after taking the dose?

If postural dizziness or presyncope occurs, the patient should immediately lie down flat or sit with the head positioned between the knees until symptoms resolve. Abrupt changes in posture should be avoided. Persistent or worsening symptoms require prompt clinical evaluation.

Can this combination therapy be taken daily on a scheduled basis?

No. This formulation is designated strictly for PRN (as-needed) administration prior to anticipated sexual activity. Continuous daily scheduled ingestion is not recommended due to elevated risks of cumulative serotonergic side effects, systemic accumulation, and cardiovascular strain.

In accordance with federal regulations.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

Additional information
Dosage

100mg+100mg

Package

40 pills

,

60 pills

,

80 pills

,

120 pills

,

180 pills

Ενεργός Ουσία

,